Key result
Gliadin induced CXCR3-dependent IL-8 production in peripheral blood mononuclear cells only in patients with coeliac disease, and not in healthy controls.
Why the study?
Does CXCR3 blockade prevent gliadin-induced cytokine release in peripheral blood mononuclear cells from patients with coeliac disease?
Does CXCR3 blockade prevent gliadin-induced cytokine release in peripheral blood mononuclear cells from patients with coeliac disease?
A specific gliadin peptide induces IL-8 production via a CXCR3-dependent mechanism exclusively in patients with coeliac disease, highlighting a potential targeted pathway in its pathogenesis.
May identify CXCR3 as a coeliac-specific target; hypothesis-generating for blockade before any clinical translation.
The autoimmune enteropathy, coeliac disease (CD), is triggered by ingestion of gluten-containing grains. We recently reported that the chemokine receptor CXCR3 serves as a receptor for specific gliadin peptides that cause zonulin release and subsequent increase in intestinal permeability. To explore the role of CXCR3 in the immune response to gliadin, peripheral blood mononuclear cells from both patients with CD and healthy controls were incubated with either pepsin-trypsin-digested gliadin or 11 α-gliadin synthetic peptides in the presence or absence of a blocking anti-CXCR3 monoclonal antibody. Supernatants were analysed for interleukin-6 (IL-6), IL-8, IL-10, IL-13, IP-10 (CXCL10), tumour necrosis factor-α and interferon-γ. Gliadin broadly induced cytokine production irrespective of the clinical condition. However, IL-8 production occurred only in a subgroup of individuals and cells of the phagocytic lineage were the main source. Induction of IL-8 was reproduced by one of a comprehensive panel of synthetic α-gliadin peptides and was abrogated when CXCR3 was blocked before stimulation with either gliadin or this peptide in the CD group but not in the control group, suggesting that gliadin-induced IL-8 production was CXCR3-dependent gliadin induced IL-8 production only in CD.
No takes yet. Share an insight, caveat, or question.
Lammers et al. (2010) studied Coeliac disease. Gliadin and synthetic α-gliadin peptides with or without anti-CXCR3 monoclonal antibody vs. Healthy controls was evaluated on Cytokine production (IL-6, IL-8, IL-10, IL-13, IP-10, TNF-α, IFN-γ). Gliadin induced CXCR3-dependent IL-8 production in peripheral blood mononuclear cells only in patients with coeliac disease, and not in healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: